A randomized pilot trial assessing the reduction of gout episodes in hyperuricemic patients by oral administration of Ligilactobacillus salivarius CECT 30632, a strain with the ability to degrade purines

INTRODUCTION: Hyperuricemia and gout are receiving an increasing scientific and medical attention because of their relatively high prevalence and their association with relevant co-morbidities. Recently, it has been suggested that gout patients have an altered gut microbiota. The first objective of...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez, Juan M., Garranzo, Marco, Segura, José, Orgaz, Belén, Arroyo, Rebeca, Alba, Claudio, Beltrán, David, Fernández, Leónides
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971985/
https://www.ncbi.nlm.nih.gov/pubmed/36865781
http://dx.doi.org/10.3389/fmicb.2023.1111652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9971985/
https://www.ncbi.nlm.nih.gov/pubmed/36865781
http://dx.doi.org/10.3389/fmicb.2023.1111652

Ejemplares similares